Last 47 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 32.93 | 31.57 | 26.48 | 18.85 | 24.60 | 25.58 | 31.48 | 20.30 | 38.22 | 26.83 | 40.53 | 22.77 | 30.18 | 35.34 | 32.50 | 42.69 | 30.39 | 40.48 | 34.41 | 43.27 | 44.69 |
| — | +23.4% | -15.9% | -7.2% | -35.6% | -4.7% | -22.3% | -10.9% | +26.7% | -24.1% | +24.7% | -46.6% | -0.7% | -12.7% | -5.5% | -1.4% | -32.0% | -39.9% | -22.3% | -40.1% | -41.0% | |
| P/S Ratio | 2.61 | 1.86 | 1.74 | 2.22 | 1.99 | 1.70 | 2.04 | 2.24 | 2.80 | 2.55 | 3.12 | 2.76 | 2.44 | 2.81 | 2.57 | 2.58 | 2.41 | 2.92 | 3.13 | 3.78 | 3.45 |
| — | +9.8% | -14.6% | -1.1% | -29.0% | -33.5% | -34.5% | -18.6% | +14.7% | -9.2% | +21.4% | +6.7% | +1.4% | -3.6% | -18.0% | -31.6% | -30.2% | -15.1% | +13.5% | +45.4% | +25.1% | |
| P/B Ratio | 6.76 | 5.17 | 4.56 | 5.84 | 5.19 | 4.72 | 5.23 | 5.86 | 6.27 | 5.80 | 7.35 | 6.98 | 6.29 | 7.30 | 6.32 | 6.70 | 6.42 | 7.75 | 7.55 | 9.10 | 8.03 |
| — | +9.6% | -12.7% | -0.2% | -17.2% | -18.7% | -28.9% | -16.1% | -0.3% | -20.5% | +16.2% | +4.1% | -2.0% | -5.8% | -16.3% | -26.3% | -20.1% | -5.5% | +25.2% | +66.7% | +59.5% | |
| P/FCF | 20.72 | 22.62 | 14.74 | 17.27 | 6.79 | 23.37 | 18.35 | 12.32 | 19.11 | 21.89 | 30.91 | 18.77 | 20.88 | 43.35 | 37.07 | 24.83 | 12.29 | 61.71 | 33.77 | 27.05 | 17.15 |
| — | -3.2% | -19.7% | +40.2% | -64.5% | +6.7% | -40.6% | -34.4% | -8.5% | -49.5% | -16.6% | -24.4% | +69.9% | -29.7% | +9.7% | -8.2% | -28.3% | +105.9% | +157.7% | +81.2% | -6.9% | |
| EV / EBITDA | 16.52 | 14.70 | 13.43 | 12.62 | 13.70 | 13.09 | 14.47 | 12.91 | 16.84 | 15.57 | 19.12 | 16.88 | 15.78 | 17.43 | 17.07 | 17.13 | 15.86 | 17.98 | 18.76 | 22.61 | 22.65 |
| — | +12.2% | -7.2% | -2.3% | -18.6% | -15.9% | -24.3% | -23.5% | +6.7% | -10.7% | +12.0% | -1.5% | -0.5% | -3.1% | -9.0% | -24.2% | -30.0% | -21.8% | +4.1% | +26.2% | +9.2% | |
| EV / EBIT | 24.79 | 23.55 | 20.71 | 18.13 | 19.26 | 20.28 | 22.56 | 16.78 | 26.87 | 20.71 | 29.28 | 24.89 | 23.17 | 25.09 | 24.58 | 31.29 | 24.41 | 31.98 | 28.95 | 35.97 | 39.59 |
| — | +16.1% | -8.2% | +8.1% | -28.3% | -2.1% | -22.9% | -32.6% | +16.0% | -17.5% | +19.1% | -20.4% | -5.1% | -21.5% | -15.1% | -13.0% | -38.4% | -31.5% | -14.0% | -6.1% | -23.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.3% | 32.9% | 32.6% | 6.7% | 33.5% | 32.9% | 33.9% | 34.8% | 35.4% | 27.7% | 34.6% | 35.9% | 35.1% | 34.5% | 34.3% | 35.6% | 34.8% | 26.8% | 34.9% | 35.0% | 33.6% |
| — | -0.3% | -3.7% | -80.8% | -5.3% | +18.8% | -2.0% | -3.1% | +0.9% | -19.6% | +0.8% | +0.9% | +0.6% | +28.7% | -1.6% | +1.8% | +3.8% | -17.5% | +6.6% | +2.5% | -5.2% | |
| Operating Margin | 14.0% | 11.6% | 12.4% | 16.8% | 13.5% | 12.6% | 13.0% | 15.8% | 14.1% | 14.4% | 13.5% | 13.0% | 12.9% | 14.1% | 12.9% | 10.1% | 13.3% | 13.2% | 13.9% | 12.9% | 8.9% |
| — | -8.0% | -4.4% | +6.1% | -4.5% | -12.3% | -4.3% | +22.1% | +9.6% | +2.2% | +5.0% | +27.8% | -2.8% | +6.7% | -7.0% | -21.2% | +48.8% | +57.2% | +38.3% | +46.9% | +32.7% | |
| Net Margin | 8.3% | 5.9% | 6.6% | 11.8% | 8.1% | 6.6% | 6.5% | 11.0% | 7.3% | 9.5% | 7.7% | 12.1% | 8.1% | 8.0% | 7.9% | 6.1% | 7.9% | 7.2% | 9.1% | 8.7% | 7.7% |
| — | -11.5% | +1.5% | +6.7% | +10.4% | -30.4% | -15.6% | -8.9% | -9.8% | +19.5% | -2.6% | +99.7% | +2.1% | +10.5% | -13.1% | -30.6% | +3.2% | +41.5% | +46.5% | +142.4% | +112.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.4% | 4.0% | 4.2% | 8.0% | 5.5% | 4.5% | 4.1% | 6.7% | 4.2% | 5.6% | 4.6% | 7.9% | 5.2% | 5.1% | 4.9% | 4.1% | 5.3% | 4.5% | 5.4% | 5.4% | 4.5% |
| — | -10.4% | +2.2% | +18.7% | +31.6% | -18.7% | -10.6% | -14.8% | -20.6% | +9.3% | -6.4% | +92.6% | -0.8% | +12.0% | -9.1% | -23.7% | +17.4% | +55.7% | +60.4% | +178.8% | +166.7% | |
| ROA | 4.8% | 0.9% | 0.9% | 1.8% | 1.2% | 1.0% | 0.9% | 1.6% | 1.1% | 1.4% | 1.1% | 1.8% | 1.2% | 1.1% | 1.1% | 0.9% | 1.2% | 1.0% | 1.3% | 1.3% | 1.1% |
| — | -9.6% | +0.1% | +8.4% | +8.5% | -30.6% | -15.1% | -9.3% | -8.7% | +19.5% | -4.4% | +94.4% | +0.1% | +10.7% | -13.6% | -29.8% | +6.9% | +43.4% | +51.4% | +165.5% | +153.3% | |
| ROIC | 8.7% | 1.8% | 1.9% | 2.7% | 2.1% | 2.0% | 2.0% | 2.5% | 2.2% | 2.2% | 2.0% | 2.0% | 2.0% | 2.2% | 2.0% | 1.7% | 2.1% | 2.0% | 2.1% | 2.1% | 1.4% |
| — | -7.1% | -6.5% | +8.6% | -3.0% | -9.9% | -2.0% | +23.1% | +11.6% | +1.8% | +2.1% | +22.3% | -6.7% | +6.4% | -7.1% | -19.8% | +55.1% | +56.1% | +41.8% | +65.6% | +67.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.44 | 2.58 | 2.53 | 2.44 | 2.42 | 2.71 | 2.42 | 2.33 | 1.97 | 2.00 | 2.17 | 2.27 | 2.39 | 2.44 | 2.26 | 2.26 | 2.37 | 2.44 | 2.19 | 2.06 | 2.14 |
| — | -5.0% | +4.4% | +4.6% | +22.8% | +35.5% | +11.9% | +2.6% | -17.6% | -17.9% | -4.3% | +0.7% | +0.8% | +0.0% | +3.5% | +9.6% | +10.4% | +11.2% | +8.4% | +0.2% | +2.9% | |
| Debt / EBITDA | 4.71 | 20.35 | 20.03 | 15.42 | 18.10 | 20.08 | 19.06 | 15.24 | 16.55 | 16.46 | 17.84 | 17.01 | 17.80 | 17.90 | 18.55 | 17.68 | 17.57 | 17.69 | 17.26 | 17.04 | 19.58 |
| — | +1.4% | +5.1% | +1.2% | +9.4% | +22.0% | +6.8% | -10.4% | -7.0% | -8.1% | -3.8% | -3.8% | +1.3% | +1.2% | +7.5% | +3.8% | -10.3% | -11.7% | -8.8% | -16.4% | -22.1% | |
| Current Ratio | 0.75 | 0.71 | 0.75 | 0.75 | 0.70 | 0.84 | 0.82 | 0.84 | 0.81 | 0.85 | 0.88 | 0.86 | 0.79 | 0.81 | 0.80 | 0.89 | 0.90 | 0.96 | 0.93 | 0.91 | 0.94 |
| — | -15.7% | -9.3% | -10.6% | -12.8% | -1.3% | -6.1% | -2.8% | +1.9% | +4.3% | +9.5% | -3.5% | -12.6% | -15.4% | -13.5% | -1.7% | -3.3% | -8.5% | -19.3% | -18.6% | -16.6% | |
| Quick Ratio | 0.75 | 0.71 | 0.75 | 0.75 | 0.70 | 0.84 | 0.82 | 0.84 | 0.81 | 0.85 | 0.88 | 0.86 | 0.79 | 0.81 | 0.80 | 0.89 | 0.90 | 0.96 | 0.93 | 0.91 | 0.94 |
| — | -15.7% | -9.3% | -10.6% | -12.8% | -1.3% | -6.1% | -2.8% | +1.9% | +4.3% | +9.5% | -3.5% | -12.6% | -15.4% | -13.5% | -1.7% | -3.3% | -8.5% | -19.3% | -18.6% | -16.6% | |
| Interest Coverage | 3.18 | 2.53 | 2.71 | 3.78 | 3.16 | 2.77 | 2.96 | 4.18 | 3.05 | 3.77 | 3.03 | 3.06 | 2.93 | 3.22 | 3.57 | 3.15 | 4.33 | 4.41 | 5.65 | 5.10 | 3.97 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IQV stock.
IQVIA Holdings Inc.'s current P/E is 32.9x. The average P/E over the last 4 quarters is 25.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
IQVIA Holdings Inc.'s current operating margin is 14.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking IQVIA Holdings Inc.'s business trajectory between earnings reports.